Global and United States Hirudin Market Insights, Forecast to 2027

Publisher Name :
Date: 01-Sep-2021
No. of pages: 133
Inquire Before Buying

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

Market Analysis and Insights: Global and United States Hirudin Market

This report focuses on global and United States Hirudin market.

In 2020, the global Hirudin market size was US$ 3867 million and it is expected to reach US$ 4774.1 million by the end of 2027, with a CAGR of 3.1% during 2021-2027. In United States the Hirudin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Hirudin Scope and Market Size

Hirudin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hirudin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Hirudin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Natural Hirudin

- Recombinant Hirudin

Segment by Application

- Thrombosis Disease

- Tumor Disease

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- The Medicines Company

- Keyken

- Minapharm

- Abbott

- SALUBRIS

- Pfizer, Inc

- Teva Pharmaceutical Industries Ltd

- DUOPUTAI

- Pentapharm

Global and United States Hirudin Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Hirudin Product Introduction
1.2 Market by Type
1.2.1 Global Hirudin Market Size Growth Rate by Type
1.2.2 Natural Hirudin
1.2.3 Recombinant Hirudin
1.3 Market by Application
1.3.1 Global Hirudin Market Size Growth Rate by Application
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hirudin Market Size, Estimates and Forecasts
2.1.1 Global Hirudin Revenue 2016-2027
2.1.2 Global Hirudin Sales 2016-2027
2.2 Global Hirudin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hirudin Historical Market Size by Region (2016-2021)
2.3.1 Global Hirudin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hirudin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hirudin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hirudin Sales Forecast by Region (2022-2027)
2.4.2 Global Hirudin Revenue Forecast by Region (2022-2027)
3 Global Hirudin Competitor Landscape by Players
3.1 Global Top Hirudin Manufacturers by Sales
3.1.1 Global Hirudin Sales by Manufacturer (2016-2021)
3.1.2 Global Hirudin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hirudin Manufacturers by Revenue
3.2.1 Key Hirudin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hirudin Revenue by Manufacturers (2016-2021)
3.2.3 Global Hirudin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hirudin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hirudin Revenue in 2020
3.2.6 Global Hirudin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hirudin Price by Manufacturers
3.4 Global Hirudin Manufacturing Base Distribution, Product Types
3.4.1 Hirudin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hirudin Product Type
3.4.3 Date of International Manufacturers Enter into Hirudin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Hirudin Market Size by Type (2016-2021)
4.1.1 Global Hirudin Sales by Type (2016-2021)
4.1.2 Global Hirudin Revenue by Type (2016-2021)
4.1.3 Hirudin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hirudin Market Size Forecast by Type (2022-2027)
4.2.1 Global Hirudin Sales Forecast by Type (2022-2027)
4.2.2 Global Hirudin Revenue Forecast by Type (2022-2027)
4.2.3 Hirudin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Hirudin Market Size by Application (2016-2021)
5.1.1 Global Hirudin Sales by Application (2016-2021)
5.1.2 Global Hirudin Revenue by Application (2016-2021)
5.1.3 Hirudin Price by Application (2016-2021)
5.2 Hirudin Market Size Forecast by Application (2022-2027)
5.2.1 Global Hirudin Sales Forecast by Application (2022-2027)
5.2.2 Global Hirudin Revenue Forecast by Application (2022-2027)
5.2.3 Global Hirudin Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Hirudin Market Size YoY Growth 2016-2027
6.1.1 United States Hirudin Sales YoY Growth 2016-2027
6.1.2 United States Hirudin Revenue YoY Growth 2016-2027
6.1.3 United States Hirudin Market Share in Global Market 2016-2027
6.2 United States Hirudin Market Size by Players (International and Local Players)
6.2.1 United States Top Hirudin Players by Sales (2016-2021)
6.2.2 United States Top Hirudin Players by Revenue (2016-2021)
6.3 United States Hirudin Historic Market Review by Type (2016-2021)
6.3.1 United States Hirudin Sales Market Share by Type (2016-2021)
6.3.2 United States Hirudin Revenue Market Share by Type (2016-2021)
6.3.3 United States Hirudin Price by Type (2016-2021)
6.4 United States Hirudin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Hirudin Sales Forecast by Type (2022-2027)
6.4.2 United States Hirudin Revenue Forecast by Type (2022-2027)
6.4.3 United States Hirudin Price Forecast by Type (2022-2027)
6.5 United States Hirudin Historic Market Review by Application (2016-2021)
6.5.1 United States Hirudin Sales Market Share by Application (2016-2021)
6.5.2 United States Hirudin Revenue Market Share by Application (2016-2021)
6.5.3 United States Hirudin Price by Application (2016-2021)
6.6 United States Hirudin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Hirudin Sales Forecast by Application (2022-2027)
6.6.2 United States Hirudin Revenue Forecast by Application (2022-2027)
6.6.3 United States Hirudin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Hirudin Market Size YoY Growth 2016-2027
7.2 North America Hirudin Market Facts & Figures by Country
7.2.1 North America Hirudin Sales by Country (2016-2021)
7.2.2 North America Hirudin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Hirudin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hirudin Market Facts & Figures by Region
8.2.1 Asia Pacific Hirudin Sales by Region (2016-2021)
8.2.2 Asia Pacific Hirudin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Hirudin Market Size YoY Growth 2016-2027
9.2 Europe Hirudin Market Facts & Figures by Country
9.2.1 Europe Hirudin Sales by Country (2016-2021)
9.2.2 Europe Hirudin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Hirudin Market Size YoY Growth 2016-2027
10.2 Latin America Hirudin Market Facts & Figures by Country
10.2.1 Latin America Hirudin Sales by Country (2016-2021)
10.2.2 Latin America Hirudin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Hirudin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hirudin Market Facts & Figures by Country
11.2.1 Middle East and Africa Hirudin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hirudin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 The Medicines Company
12.1.1 The Medicines Company Corporation Information
12.1.2 The Medicines Company Description and Business Overview
12.1.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 The Medicines Company Hirudin Products Offered
12.1.5 The Medicines Company Recent Development
12.2 Keyken
12.2.1 Keyken Corporation Information
12.2.2 Keyken Description and Business Overview
12.2.3 Keyken Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Keyken Hirudin Products Offered
12.2.5 Keyken Recent Development
12.3 Minapharm
12.3.1 Minapharm Corporation Information
12.3.2 Minapharm Description and Business Overview
12.3.3 Minapharm Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Minapharm Hirudin Products Offered
12.3.5 Minapharm Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Description and Business Overview
12.4.3 Abbott Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Hirudin Products Offered
12.4.5 Abbott Recent Development
12.5 SALUBRIS
12.5.1 SALUBRIS Corporation Information
12.5.2 SALUBRIS Description and Business Overview
12.5.3 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 SALUBRIS Hirudin Products Offered
12.5.5 SALUBRIS Recent Development
12.6 Pfizer, Inc
12.6.1 Pfizer, Inc Corporation Information
12.6.2 Pfizer, Inc Description and Business Overview
12.6.3 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer, Inc Hirudin Products Offered
12.6.5 Pfizer, Inc Recent Development
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Industries Ltd Hirudin Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd Recent Development
12.8 DUOPUTAI
12.8.1 DUOPUTAI Corporation Information
12.8.2 DUOPUTAI Description and Business Overview
12.8.3 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 DUOPUTAI Hirudin Products Offered
12.8.5 DUOPUTAI Recent Development
12.9 Pentapharm
12.9.1 Pentapharm Corporation Information
12.9.2 Pentapharm Description and Business Overview
12.9.3 Pentapharm Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pentapharm Hirudin Products Offered
12.9.5 Pentapharm Recent Development
12.11 The Medicines Company
12.11.1 The Medicines Company Corporation Information
12.11.2 The Medicines Company Description and Business Overview
12.11.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 The Medicines Company Hirudin Products Offered
12.11.5 The Medicines Company Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hirudin Industry Trends
13.2 Hirudin Market Drivers
13.3 Hirudin Market Challenges
13.4 Hirudin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hirudin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Hirudin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Natural Hirudin
Table 3. Major Manufacturers of Recombinant Hirudin
Table 4. Global Hirudin Market Size Growth Rate by Application (2021-2027) & (MT)
Table 5. Global Hirudin Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Hirudin Sales by Regions (2016-2021) & (MT)
Table 7. Global Hirudin Sales Market Share by Regions (2016-2021)
Table 8. Global Hirudin Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Hirudin Sales Forecast by Region (2022-2027) & (MT)
Table 10. Global Hirudin Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Hirudin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Hirudin Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Hirudin Sales by Manufacturers (2016-2021) (MT)
Table 14. Global Hirudin Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Hirudin Manufacturers by Revenue (US$ Million) in 2020
Table 16. Hirudin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Hirudin Revenue Share by Manufacturers (2016-2021)
Table 18. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Hirudin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hirudin as of 2020)
Table 20. Key Manufacturers Hirudin Price (2016-2021) (USD/Kg)
Table 21. Hirudin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hirudin Product Type
Table 23. Date of International Manufacturers Enter into Hirudin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hirudin Sales by Type (2016-2021) (MT)
Table 26. Global Hirudin Sales Share by Type (2016-2021)
Table 27. Global Hirudin Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Hirudin Revenue Share by Type (2016-2021)
Table 29. Hirudin Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 30. Global Hirudin Sales Forecast by Type (2022-2027) & (MT)
Table 31. Global Hirudin Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Hirudin Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Hirudin Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Hirudin Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Hirudin Sales by Application (2016-2021) (MT)
Table 36. Global Hirudin Sales Share by Application (2016-2021)
Table 37. Global Hirudin Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Hirudin Revenue Share by Application (2016-2021)
Table 39. Hirudin Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 40. Global Hirudin Sales Forecast by Application (2022-2027) & (MT)
Table 41. Global Hirudin Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Hirudin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Hirudin Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Hirudin Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 45. United States Hirudin Sales (MT) of Key Companies (2016-2021)
Table 46. United States Hirudin Sales Share by Company (2016-2021)
Table 47. United States Hirudin Revenue (US$ Million) by Company (2016-2021)
Table 48. United States Hirudin Revenue Share by Company (2016-2021)
Table 49. United States Hirudin Sales (MT) by Type (2016-2021)
Table 50. United States Hirudin Sales Share by Type (2016-2021)
Table 51. United States Hirudin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States Hirudin Price (USD/Kg) by Type (2016-2021)
Table 53. United States Hirudin Sales (MT) by Type (2022-2027)
Table 54. United States Hirudin Sales Share by Type (2022-2027)
Table 55. United States Hirudin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States Hirudin Revenue Share by Type (2022-2027)
Table 57. United States Hirudin Price (USD/Kg) by Type (2022-2027)
Table 58. United States Hirudin Sales (MT) by Application (2016-2021)
Table 59. United States Hirudin Sales Share by Application (2016-2021)
Table 60. United States Hirudin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States Hirudin Price (USD/Kg) by Application (2016-2021)
Table 62. United States Hirudin Sales (MT) by Application (2022-2027)
Table 63. United States Hirudin Sales Share by Application (2022-2027)
Table 64. United States Hirudin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States Hirudin Revenue Share by Application (2022-2027)
Table 66. United States Hirudin Price (USD/Kg) by Application (2022-2027)
Table 67. North America Hirudin Sales by Country (2016-2021) & (MT)
Table 68. North America Hirudin Sales Market Share by Country (2016-2021)
Table 69. North America Hirudin Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Hirudin Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Hirudin Sales by Region (2016-2021) & (MT)
Table 72. Asia Pacific Hirudin Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Hirudin Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Hirudin Revenue Market Share by Region (2016-2021)
Table 75. Europe Hirudin Sales by Country (2016-2021) & (MT)
Table 76. Europe Hirudin Sales Market Share by Country (2016-2021)
Table 77. Europe Hirudin Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Hirudin Revenue Market Share by Country (2016-2021)
Table 79. Latin America Hirudin Sales by Country (2016-2021) & (MT)
Table 80. Latin America Hirudin Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Hirudin Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Hirudin Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Hirudin Sales by Country (2016-2021) & (MT)
Table 84. Middle East and Africa Hirudin Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Hirudin Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Hirudin Revenue Market Share by Country (2016-2021)
Table 87. The Medicines Company Corporation Information
Table 88. The Medicines Company Description and Business Overview
Table 89. The Medicines Company Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 90. The Medicines Company Hirudin Product
Table 91. The Medicines Company Recent Development
Table 92. Keyken Corporation Information
Table 93. Keyken Description and Business Overview
Table 94. Keyken Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 95. Keyken Product
Table 96. Keyken Recent Development
Table 97. Minapharm Corporation Information
Table 98. Minapharm Description and Business Overview
Table 99. Minapharm Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Minapharm Product
Table 101. Minapharm Recent Development
Table 102. Abbott Corporation Information
Table 103. Abbott Description and Business Overview
Table 104. Abbott Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 105. Abbott Product
Table 106. Abbott Recent Development
Table 107. SALUBRIS Corporation Information
Table 108. SALUBRIS Description and Business Overview
Table 109. SALUBRIS Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 110. SALUBRIS Product
Table 111. SALUBRIS Recent Development
Table 112. Pfizer, Inc Corporation Information
Table 113. Pfizer, Inc Description and Business Overview
Table 114. Pfizer, Inc Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 115. Pfizer, Inc Product
Table 116. Pfizer, Inc Recent Development
Table 117. Teva Pharmaceutical Industries Ltd Corporation Information
Table 118. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 119. Teva Pharmaceutical Industries Ltd Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 120. Teva Pharmaceutical Industries Ltd Product
Table 121. Teva Pharmaceutical Industries Ltd Recent Development
Table 122. DUOPUTAI Corporation Information
Table 123. DUOPUTAI Description and Business Overview
Table 124. DUOPUTAI Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 125. DUOPUTAI Product
Table 126. DUOPUTAI Recent Development
Table 127. Pentapharm Corporation Information
Table 128. Pentapharm Description and Business Overview
Table 129. Pentapharm Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. Pentapharm Product
Table 131. Pentapharm Recent Development
Table 132. Hirudin Market Trends
Table 133. Hirudin Market Drivers
Table 134. Hirudin Market Challenges
Table 135. Hirudin Market Restraints
Table 136. Hirudin Customers List
Table 137. Hirudin Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Hirudin Product Picture
Figure 2. Global Hirudin Sales Market Share by Type in 2020 & 2027
Figure 3. Natural Hirudin Product Picture
Figure 4. Recombinant Hirudin Product Picture
Figure 5. Global Hirudin Sales Market Share by Application in 2020 & 2027
Figure 6. Thrombosis Disease
Figure 7. Tumor Disease
Figure 8. Others
Figure 9. Hirudin Report Years Considered
Figure 10. Global Hirudin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hirudin Market Size 2016-2027 (US$ Million)
Figure 12. Global Hirudin Sales 2016-2027 (MT)
Figure 13. Global Hirudin Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Hirudin Sales Market Share by Region (2016-2021)
Figure 15. Global Hirudin Sales Market Share by Region in 2020
Figure 16. Global Hirudin Revenue Market Share by Region (2016-2021)
Figure 17. Global Hirudin Revenue Market Share by Region in 2020
Figure 18. Global Hirudin Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Hirudin Revenue in 2020
Figure 20. Hirudin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Hirudin Sales Market Share by Type (2016-2021)
Figure 22. Global Hirudin Sales Market Share by Type in 2020
Figure 23. Global Hirudin Revenue Market Share by Type (2016-2021)
Figure 24. Global Hirudin Revenue Market Share by Type in 2020
Figure 25. Global Hirudin Sales Market Share by Application (2016-2021)
Figure 26. Global Hirudin Sales Market Share by Application in 2020
Figure 27. Global Hirudin Revenue Market Share by Application (2016-2021)
Figure 28. Global Hirudin Revenue Market Share by Application in 2020
Figure 29. United States Hirudin Sales Growth Rate 2016-2027 (MT)
Figure 30. United States Hirudin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Hirudin Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Hirudin Players Market Share by Revenue in Hirudin in 2020
Figure 33. United States Hirudin Revenue Share by Type (2016-2021)
Figure 34. United States Hirudin Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Hirudin Revenue Share by Application (2016-2021)
Figure 36. United States Hirudin Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Hirudin Sales Growth Rate 2016-2021 (MT)
Figure 38. North America Hirudin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Hirudin Sales Market Share by Country in 2020
Figure 40. North America Hirudin Revenue Market Share by Country in 2020
Figure 41. U.S. Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 42. U.S. Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 44. Canada Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Hirudin Sales Growth Rate 2016-2021 (MT)
Figure 46. Europe Hirudin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Hirudin Sales Market Share by Country in 2020
Figure 48. Europe Hirudin Revenue Market Share by Country in 2020
Figure 49. Germany Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 50. Germany Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 52. France Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 54. U.K. Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 56. Italy Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 58. Russia Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Hirudin Sales Growth Rate 2016-2021 (MT)
Figure 60. Asia Pacific Hirudin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Hirudin Sales Market Share by Region in 2020
Figure 62. Asia Pacific Hirudin Revenue Market Share by Region in 2020
Figure 63. China Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 64. China Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 66. Japan Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 68. South Korea Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 70. India Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 72. Australia Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 74. China Taiwan Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 76. Indonesia Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 78. Thailand Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 80. Malaysia Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Hirudin Sales Growth Rate 2016-2021 (MT)
Figure 82. Latin America Hirudin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Hirudin Sales Market Share by Country in 2020
Figure 84. Latin America Hirudin Revenue Market Share by Country in 2020
Figure 85. Mexico Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 86. Mexico Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 88. Brazil Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 90. Argentina Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Hirudin Sales Growth Rate 2016-2021 (MT)
Figure 92. Middle East and Africa Hirudin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Hirudin Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Hirudin Revenue Market Share by Country in 2020
Figure 95. Turkey Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 96. Turkey Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 98. Saudi Arabia Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Hirudin Sales Growth Rate (2016-2021) (MT)
Figure 100. UAE Hirudin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Hirudin Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs